Omeros Corporation - Common Stock (OMER)
7.3600
-0.6500 (-8.11%)
NASDAQ · Last Trade: Apr 4th, 3:35 AM EDT

OMER stock results show that Omeros missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 7, 2024

OMER stock results show that Omeros missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024
Via Benzinga · March 28, 2025
Via Benzinga · March 17, 2025
Via Benzinga · March 17, 2025

Via Benzinga · December 23, 2024

OMER stock results show that Omeros missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 1, 2024

Via Benzinga · December 19, 2024

Via Benzinga · December 19, 2024

Omeros announces positive results from a pivotal narsoplimab trial in TA-TMA, showing significant survival benefits and advancing regulatory submissions.
Via Benzinga · December 19, 2024

Via Benzinga · December 19, 2024

Via Benzinga · December 3, 2024

Via Benzinga · November 22, 2024

Via Benzinga · November 18, 2024

Via Benzinga · May 16, 2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Via Benzinga · April 1, 2024

The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged to a new all-time high and also recorded its best first-quarter performance in five years.
Via Benzinga · April 1, 2024